 Effect cyclosporine hearing loss Behcet disease Thirty-five patients Behcet disease cyclosporine CyA treatment conventional therapy patients endogenous uveitis normal subjects study year Twenty-eight Behcet patients degree hearing loss averaged pure tone audiogram Behcet group significant auditory deficits comparison control group None Behcet group uveitis group hearing deterioration follow-up period patients CyA therapy improvement hearing difference groups Behcet patients CyA versus conventional treatment significant CyA important mode treatment sensorineural hearing loss inflammatory autoimmune background